Facebook X (Twitter) Instagram
    Facebook Instagram Threads
    Global BiodefenseGlobal Biodefense
    Subscribe
    • Featured News
    • Funding
    • Directory
    • Jobs
    • Events
    Global BiodefenseGlobal Biodefense
    Contracts + Grants

    Nanostructured Active Therapeutics Proposal Deadline Extended

    By Global Biodefense StaffDecember 31, 2012
    Share
    Facebook LinkedIn Reddit Email

    The Defense Threat Reduction Agency (DTRA) Chemical and Biological Defense Program (CBDP) has extended the proposal receipt deadline for the Nanostructured Active Therapeutic Vehicles (NATV) initiative. 

    The NATV program seeks to advance nanostructured therapeutic materials designed for prophylactic or pre-symptomatic chemical and biological medical countermeasures. Two target-centric thrust areas are emphasized for novel advances: 

    Thrust 1: Small-molecule antibiotics, such as those used against Gram-negative bacterial pathogens, particularly Burkholderia mallei and Francisella tularensis. A particular challenge in this thrust is demonstration of targeting infected cells and transport of the therapeutic into the bacterium. 

    Thrust 2: Large-molecule bioscavenger Butyrylcholinesterase (BuChE) to deliver broad-spectrum protection against all classes of nerve agents. 

    The new submission date for proposals is January 25, 2013. Selections are expected to be announced on February 28, 2013. 

    BAA Bioscavengers Burkholderia Defense Threat Reduction Agency F. tularensis Nanotech
    Share. Facebook LinkedIn Reddit Email
    Previous ArticleBiodefense Headlines – December 16, 2012
    Next Article FDA Initiative to Speed Medical Device Development

    Related Stories

    Jurata Thin Film and CastleVax Awarded Grant to Advance Thermostabilized COVID-19 Booster

    September 20, 2023

    Mount Sinai to Lead Development of Pan-Coronavirus Vaccine Under New Federal Grant

    September 17, 2023

    NIAID Seeks to Improve Computational Models of Influenza Immunity

    September 15, 2023

    Smallpox Vaccines: Bavarian Nordic Awarded Another Contract to Supply EU Strategic Reserve

    September 13, 2023
    News Scan

    Biodefense Headlines – 19 September 2023

    News Scan September 19, 2023

    News highlights on health security threats and countermeasures curated by Global Biodefense This week’s selections include a global survey of gain-of-function research; funding of an mRNA mpox vaccine; Nipah virus outbreak in India; field detection of threat agents with acoustic…

    Upcoming Events

    Oct 3
    Virtual Event Virtual Event
    October 3 - October 5

    OneLab Summit 2023

    Oct 3
    Virtual Event Virtual Event
    12:00 pm - 2:00 pm EDT

    Public-Private Partnerships to Distribute, Dispense, and Administer Medical Countermeasures

    Oct 4
    Virtual Event Virtual Event
    10:00 am - 2:00 pm EDT

    Tunneling Nanotubes and Intracellular Protrusions Workshop

    Oct 12
    Virtual Event Virtual Event
    12:00 pm - 2:00 pm EDT

    Public-Private Partnerships for Acceptance and Uptake of Medical Countermeasures

    View Calendar

    Subscribe to Global Biodefense

    Get the latest news on pathogens and preparedness

    © 2023 Stemar Media Group LLC
    • About
    • Contact
    • Privacy
    • Subscribe

    Type above and press Enter to search. Press Esc to cancel.